๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-02-12

Romosozumab Use to Build Skeletal Integrity (NCT05058976)

Innovative Approach to Geriatric Osteoporosis

๐Ÿ”ต Active, Not Recruiting Phase4 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: Susan L. Greenspan

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The purpose of this study is to find out if one year of romosozumab (Evenityยฎ), a monthly injection given in the arm under the skin, prior to an infusion of zoledronic acid Reclastยฎ, works to treat bone loss and prevent it from worsening in older women (ages 65 and older) who have osteoporosis and reside in long-term care (LTC) facilities.

Who can join: Review the eligibility criteria below.

Location: UPMC Senior Communities โ€” Pittsburgh, Pennsylvania

Age range: 65 Years

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • UPMC Senior Communities โ€” Pittsburgh, Pennsylvania

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Osteoporosis clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—